High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases

Ann Rheum Dis. 2021 Oct;80(10):1351-1352. doi: 10.1136/annrheumdis-2021-220656. Epub 2021 May 24.
No abstract available

Keywords: COVID-19; autoimmune diseases; epidemiology; vaccination.

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • Antirheumatic Agents / therapeutic use
  • COVID-19 / prevention & control*
  • Female
  • Humans
  • Immunocompromised Host / immunology*
  • Immunogenicity, Vaccine / drug effects
  • Immunogenicity, Vaccine / immunology*
  • Male
  • Middle Aged
  • Rheumatic Diseases / drug therapy
  • Rheumatic Diseases / immunology*
  • SARS-CoV-2

Substances

  • Antibodies, Viral
  • Antirheumatic Agents